Express Pharma - Express Pharma

Company brings isolator technology to sterile injectable manufacturing in India

Company secures final ANDA approval with eligibility for 180 days of CGT exclusivity

Programme records participation across premier management institutes and announces teams recognised in the grand finale

Partnership aims to expand access to treatment options for Hutchinson-Gilford Progeria Syndrome and Progeroid Laminopathies

The single-dose vial is bioequivalent to Hospira’s reference product and will enter the US market later this year

Company to distribute and promote the once-weekly injectable therapy following Lilly’s DCGI approval

Manjiri Gharat,FIP India Envoy; VP,SEARPharm Forum of FIP; I/C Principal,K.M.Kundnani Pharmacy Polytechnic,Ulhasnagar; Former…

Approval enables access to targeted therapy for adults and adolescents aged 12 and above following surgery

Biocon Group Chairperson recognised in Mumbai ceremony for contributions to global healthcare and biotechnology

Formycon to develop and supply Pembrolizumab biosimilar FYB206, while Zydus Lifesciences will commercialise the product in the USA…